drugset / Trial / NCT03596086
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Phase 1/2
Recruiting
62 enrolled
David Baskin MD
Center for Cell and Gene Therapy, Baylor College of Medicine · collabThe Methodist Hospital Research Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclovir, radiotherapy and chemotherapy in recurrent glioblastoma multiforme.
Timeline
- Start
- 2017-12-11
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSV-Tk | Cell therapy | — | Other |